pre-bronchodilator FEV1 at Week 52. Tezepelumab is being developed by AstraZeneca in collaboration with Amgen as a ...

In May 2024, GSK announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and safety of depemokimab versus placebo in adults and ...

A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

TURIN, Italy I October 30, 2024 I Kither Biotech, a clinical-stage biotech company focused on innovative therapies for respiratory diseases, today announced ...

The BRICS mechanism is the world's most important platform for solidarity and cooperation between emerging markets and developing countries, said Chinese President Xi Jinping when meeting with Russian ...

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack—blocking the energy supply T cells depend on. The work ...

Background: In contrast to asthma, the indication for bronchodilators prior to bronchoscopy in patients with COPD has not been properly investigated. We therefore performed a randomized ...

Although this defense mechanism may mediate bronchoconstriction in both normal and asthmatic individuals, in asthmatics this airway response develops at lower levels of stimulation and the ...

For treatments of CB, inhaled corticosteroid and bronchodilators, oral prednisone (15 mg per day) and azithromycin were administrated. Intravenous immunoglobulin was used in the perioperative period ...